These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7254432)

  • 1. Therapeutic evaluation of liposome-encapsulated Daunoblastin in murine tumor models.
    Fichtner I; Reszka R; Elbe B; Arndt D
    Neoplasma; 1981; 28(2):141-9. PubMed ID: 7254432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Liposome encapsulation as a possibility for the improvement of tumor chemotherapy].
    Fichtner I; Reszka R; Elbe B; Arndt D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):658-63. PubMed ID: 6172330
    [No Abstract]   [Full Text] [Related]  

  • 3. Anthracycline antibiotics with high liposome entrapment: structural features and biological activity.
    Perez-Soler R; Priebe W
    Cancer Res; 1990 Jul; 50(14):4260-6. PubMed ID: 2194651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic efficacy of Nocodazole encapsulated in liposomes on L1210 murine leukemia.
    Laduron C; Coune A; Atassi G; Hildebrand J; Ruysschaert JM; Stryckmans P; Brassinne C
    Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):419-36. PubMed ID: 6190203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved therapeutic benefits of doxorubicin by entrapment in anionic liposomes.
    Forssen EA; Tökés ZA
    Cancer Res; 1983 Feb; 43(2):546-50. PubMed ID: 6848178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers.
    Arcamone F; Bernardi L; Giardino P; Patelli B; Marco A; Casazza AM; Pratesi G; Reggiani P
    Cancer Treat Rep; 1976 Jul; 60(7):829-34. PubMed ID: 1009518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of daunorubicin encapsulated in liposome for the treatment of proliferative vitreoretinopathy.
    Shinohara K; Tanaka M; Sakuma T; Kobayashi Y
    Ophthalmic Surg Lasers Imaging; 2003; 34(4):299-305. PubMed ID: 12875458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation, properties and therapeutic effect of Daunorubicin-containing liposomes].
    Arndt D; Fichtner I; Reszka R; Elbe B
    Pharmazie; 1983 May; 38(5):331-5. PubMed ID: 6611631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models.
    Tardi P; Choice E; Masin D; Redelmeier T; Bally M; Madden TD
    Cancer Res; 2000 Jul; 60(13):3389-93. PubMed ID: 10910044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J; Lee A; Lu Y; Lee RJ
    Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone.
    Lim HJ; Masin D; Madden TD; Bally MB
    J Pharmacol Exp Ther; 1997 Apr; 281(1):566-73. PubMed ID: 9103545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacy.
    Schwendener RA; Fiebig HH; Berger MR; Berger DP
    Cancer Chemother Pharmacol; 1991; 27(6):429-39. PubMed ID: 2013113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissue.
    Forssen EA; Malé-Brune R; Adler-Moore JP; Lee MJ; Schmidt PG; Krasieva TB; Shimizu S; Tromberg BJ
    Cancer Res; 1996 May; 56(9):2066-75. PubMed ID: 8616852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.
    Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S
    Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved safety, pharmacokinetics and therapeutic efficacy profiles of a novel liposomal formulation of mitoxantrone.
    Gokhale PC; Pei J; Zhang C; Ahmad I; Rahman A; Kasid U
    Anticancer Res; 2001; 21(5):3313-21. PubMed ID: 11848489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental findings concerning the anti-tumor properties of nordopan glucosides].
    Popov DV; Platonova GN; Studentsov EP; Larionov LF
    Biull Eksp Biol Med; 1973 May; 75(5):73-5. PubMed ID: 4778694
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo.
    Ganapathi R; Krishan A; Wodinsky I; Zubrod CG; Lesko LJ
    Cancer Res; 1980 Mar; 40(3):630-3. PubMed ID: 7471083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats.
    Yokoe J; Sakuragi S; Yamamoto K; Teragaki T; Ogawara K; Higaki K; Katayama N; Kai T; Sato M; Kimura T
    Int J Pharm; 2008 Apr; 353(1-2):28-34. PubMed ID: 18082345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.